| 000 | 01881 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517035702.0 | ||
| 264 | 0 | _c20160509 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1098-660X | ||
| 024 | 7 |
_a10.1128/JCM.00622-15 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYong, Lee K | |
| 245 | 0 | 0 |
_aMorphological and Molecular Characterization of Exophiala polymorpha sp. nov. Isolated from Sporotrichoid Lymphocutaneous Lesions in a Patient with Myasthenia Gravis. _h[electronic resource] |
| 260 |
_bJournal of clinical microbiology _cSep 2015 |
||
| 300 |
_a2816-22 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntifungal Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aCluster Analysis |
| 650 | 0 | 4 |
_aDNA, Fungal _xchemistry |
| 650 | 0 | 4 |
_aDNA, Ribosomal Spacer _xchemistry |
| 650 | 0 | 4 |
_aDermatomycoses _xdiagnosis |
| 650 | 0 | 4 |
_aExophiala _xclassification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHistocytochemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aItraconazole _xtherapeutic use |
| 650 | 0 | 4 | _aMicrobiological Techniques |
| 650 | 0 | 4 | _aMicroscopy |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aMyasthenia Gravis _xcomplications |
| 650 | 0 | 4 |
_aPeptide Elongation Factor 1 _xgenetics |
| 650 | 0 | 4 |
_aPhaeohyphomycosis _xdiagnosis |
| 650 | 0 | 4 | _aPhylogeny |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTubulin _xgenetics |
| 700 | 1 | _aWiederhold, Nathan P | |
| 700 | 1 | _aSutton, Deanna A | |
| 700 | 1 | _aSandoval-Denis, Marcelo | |
| 700 | 1 | _aLindner, Jonathan R | |
| 700 | 1 | _aFan, Hongxin | |
| 700 | 1 | _aSanders, Carmita | |
| 700 | 1 | _aGuarro, Josep | |
| 773 | 0 |
_tJournal of clinical microbiology _gvol. 53 _gno. 9 _gp. 2816-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JCM.00622-15 _zAvailable from publisher's website |
| 999 |
_c24992714 _d24992714 |
||